Rui Pascoal

发表

Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.

I. Santana, C. Oliveira, I. Baldeiras, 2008, Journal of Alzheimer's disease : JAD.

Oxidative damage and mitochondrial dysfunction in patients with mild cognitive impairment and Alzheimer's disease

I. Santana, I. Baldeiras, C. Oliveira, 2010, Alzheimer's & Dementia.

Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment.

I. Santana, C. Oliveira, I. Baldeiras, 2010, Journal of Alzheimer's disease : JAD.

Cigarette Smoking Increases Oxidative Stress in Prostate Cancer Patients – A Preliminary Study

A. Sarmento-Ribeiro, A. Mota-Pinto, I. Baldeiras, 2007 .

Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.

I. Santana, A. Gabriel, I. Baldeiras, 2018, Journal of Alzheimer's disease : JAD.

Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer’s disease patients

I. Santana, A. Gabriel, I. Baldeiras, 2017, Neuroscience Letters.

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease

I. Santana, Raquel Lemos, C. Oliveira, 2015, Journal of the Neurological Sciences.

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

I. Santana, I. Baldeiras, C. Oliveira, 2018, Alzheimer's research & therapy.

Phospholipase A2 and Ischemic Stroke Etiology

G. Santo, J. Sargento-Freitas, L. Almendra, 2021, The neurologist.

Multiple sclerosis: Association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the disease.

A. Valado, J. Cerqueira, I. Baldeiras, 2017, Multiple sclerosis and related disorders.

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

I. Santana, I. Baldeiras, C. Oliveira, 2018, Alzheimer's Research & Therapy.

Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer’s disease patients

I. Santana, A. Gabriel, I. Baldeiras, 2017, Neuroscience Letters.

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease

I. Santana, Raquel Lemos, C. Oliveira, 2015, Journal of the Neurological Sciences.

Comparison of Sickle SCAN and Hemotype SC As Point-of-Care Newborn Screening Diagnostics for Sickle Cell Disease in Luanda, Angola

Brígida Santos, Patrick T. McGann, Rui Pascoal, 2021, Blood.